Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party.
Abou Dalle, Iman ; Bone marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Labopin, Myriam ; Hospital Saint-Antoine, Sorbonne University, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Paris, France ; European Society for Blood and Marrow Transplantation Statistical Unit, Hôpital Saint-Antoine, Paris, France
Khvedelidze, Irma; European Society for Blood and Marrow Transplantation Paris Study Unit, Hôpital Saint-Antoine, Paris, France
Baron, Frédéric ; Université de Liège - ULiège > Département des sciences cliniques
Brissot, Eolia ; Hospital Saint-Antoine, Sorbonne University, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Paris, France
Bug, Gesine ; Department of Medicine 2, Hematology and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany
Esteve, Jordi ; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain
Giebel, Sebastian ; Department of Bone Marrow Transplantation and Oncohematology, Gliwice, Poland
Gorin, Norbert-Claude ; Hospital Saint-Antoine, Sorbonne University, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Paris, France ; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France ; Department of Haematology and Cell Therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France ; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Paris, France
Lanza, Francesco ; Hematology Unit, Romagna Transplant Network, Ravenna, University of Bologna, Bologna, Italy
Nagler, Arnon; Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel
Peric, Zina ; University Hospital Center Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia
Piemontese, Simona ; Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Hospital, Milan, Italy
Ruggeri, Annalisa ; Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Hospital, Milan, Italy
Sanz, Jaime ; University Hospital La Fe, Valencia, Spain
Savani, Bipin ; Department of Haematology-Oncology, Vanderbilt University, Medical Center, Nashville, TN, USA
Schmid, Christoph ; Department of Hematology and Oncology, Augsburg University Hospital, Augsburg, Germany
Shouval, Roni ; Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA
Spyridonidis, Alexandros ; BMT Unit and Institute of Cell Therapy, University of Patras, Patras, Greece
Versluis, Jurjen ; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands
Ciceri, Fabio ; Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Hospital, Milan, Italy
Bazarbachi, Ali ; Bone marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. bazarbac@aub.edu.lb
Mohty, Mohamad ; Hospital Saint-Antoine, Sorbonne University, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Paris, France
Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party.
C. Craddock J. Versluis M. Labopin G. Socie A. Huynh E. Deconinck et al. Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia J Intern Med 283 371 9 1:CAS:528:DC%2BC1cXmt1WlsLY%3D 10.1111/joim.12720 29214689
Abou Dalle I, El Cheikh J, Bazarbachi A. Pharmacologic strategies for post-transplant maintenance in acute myeloid Leukemia: It Is Time to Consider! Cancers 2022; 14. https://doi.org/10.3390/cancers14061490.
B. Oran M. de Lima G. Garcia-Manero P.F. Thall R. Lin U. Popat et al. A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Blood Adv 4 5580 8 1:CAS:528:DC%2BB3cXis12ks7zP 10.1182/bloodadvances.2020002544 33170934 7656915
Gao L, Zhang Y, Wang S, Kong P, Su Y, Hu J et al. Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: an open-label, multicenter, randomized controlled trial. J Clin Oncol 2020:Jco1903277. https://doi.org/10.1200/jco.19.03277.
A. Burchert G. Bug L.V. Fritz J. Finke M. Stelljes C. Röllig et al. Sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for acute myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN) J Clin Oncol 38 2993 3002 10.1200/jco.19.03345 32673171
L. Xuan Y. Wang F. Huang Z. Fan Y. Xu J. Sun et al. Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial Lancet Oncol 21 1201 12 1:CAS:528:DC%2BB3cXhsFygsrjM 10.1016/s1470-2045(20)30455-1 32791048
A. Bazarbachi M. Labopin G. Battipaglia A. Djabali E. Forcade W. Arcese et al. Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell depletion and posttransplant sorafenib maintenance improve survival. A retrospective acute leukemia working party-European society for blood and marrow transplant study Clin Hematol Int 1 58 74 10.2991/chi.d.190310.001 34595412 8432385
M.J. Levis M. Hamadani B. Logan R.J. Jones A.K. Singh M. Litzow et al. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 J Clin Oncol 42 1766 75 1:CAS:528:DC%2BB2cXhtVGks7rM 10.1200/jco.23.02474 38471061
J.P. Bewersdorf M.S. Tallman C. Cho A.M. Zeidan M. Stahl Safety and efficacy of maintenance treatment following allogeneic hematopoietic cell transplant in acute myeloid leukemia and myelodysplastic syndrome - a systematic review and meta-analysis Blood 136 34 5 10.1182/blood-2020-136671
A. Bazarbachi G. Bug F. Baron E. Brissot F. Ciceri I.A. Dalle et al. Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Haematologica 105 1507 16 1:CAS:528:DC%2BB3cXhvFOmu7vI 10.3324/haematol.2019.243410 32241850 7271578
D.A. Pollyea J.K. Altman R. Assi D. Bixby A.T. Fathi J.M. Foran et al. Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Canc Netw 21 503 13 1:CAS:528:DC%2BB3sXhsVems7fE 10.6004/jnccn.2023.0025 37156478
J.S. Garcia H.T. Kim H.M. Murdock M. Ansuinelli J. Brock C.S. Cutler et al. Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML Blood Adv 8 978 90 1:CAS:528:DC%2BB2cXjvFWls74%3D 10.1182/bloodadvances.2023012120 38197938 10883823
